WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
PATENTSCOPE will be unavailable a few hours for maintenance reason on Saturday 18.08.2018 at 9:00 AM CEST
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2003000175) PEDIATRIC FORMULATION OF GATIFLOXACIN
Latest bibliographic data on file with the International Bureau   

Pub. No.: WO/2003/000175 International Application No.: PCT/US2002/014596
Publication Date: 03.01.2003 International Filing Date: 10.05.2002
Chapter 2 Demand Filed: 13.01.2003
IPC:
C07D 215/56 (2006.01)
Applicants: BRISTOL-MYERS SQUIBB COMPANY[US/US]; P.O. Box 4000 Princeton, NJ 08543-4000, US
Inventors: RAGHAVAN, Krishnaswamy, S.; US
RANADIVE, Sunanda, A.; US
BEMBENEK, Kenneth, S.; US
BENKERROUR, Loutfy; FR
TROGNON, Veronique; FR
CORRAO, Richard, G.; US
ESPOSITO, Luigi; US
Agent: MORSE, David, M.; Bristol-Myers Squibb Company P.O. Box 4000 Princeton, NJ 08543-4000, US
VOLLES, Warren, K.; BRISTOL-MYERS SQUIBB COMPANY P.O. Box 4000 Princeton, NJ 08543-4000, US
Priority Data:
60/299,62520.06.2001US
Title (EN) PEDIATRIC FORMULATION OF GATIFLOXACIN
(FR) FORMULATION PEDIATRIQUE DE GATIFLOXACINE
Abstract:
(EN) There is provided in accordance with the present invention the quinolone antibacterial gatifloxacin adequately taste-masked so that it can be utilized for pediatric formulations. A crystalline co-precipitate of gatifloxacin and one or both of stearic acid and palmitic acid in a narrow weight ratio has been found to effectively mask the bitter taste of gatifloxacin. The taste of gatifloxacin is effectively masked in the mouth and in aqueous suspension through a full dosage cycle, typically fourteen days. Gatifloxacin in the subject crystalline co-precipitates has been found to be readily available for absorption from the stomach.
(FR) L'invention concerne la gatifloxacine antibactérienne de la quinolone, dont le goût est adéquatement masqué afin que l'on puisse l'utiliser dans des formulations pédiatriques. Un co-précipité cristallin de la gatifloxacine et d'au moins un des deux acide stéarique et acide palmitique, dans un rapport de masse étroit, masque efficacement le goût amer de la gatifloxacine. Le goût de la gatifloxacine est efficacement masqué dans la bouche et en suspension aqueuse durant un cycle posologique complet, d'ordinaire quatorze jours. Dans ces co-précipités cristallins, la gatifloxacine s'est avérée d'absorption facilement assimilable de l'estomac.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, OM, PH, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TN, TR, TT, TZ, UA, UG, UZ, VN, YU, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (EPO) (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)